Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
Feature
14 Nov 2024
Employing ML to boost pharmacokinetics in drug development
Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval. Continue Reading
-
Podcast
13 Nov 2024
Exploring gaps in GLP-1 research, care and coverage
Dr. Lydia Alexander discusses progress in obesity management and identifies gaps in GLP-1 research, care delivery and insurance coverage on 'Healthcare Strategies.' Continue Reading
-
News
22 Dec 2021
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
FDA approves Pfizer’s tofacitinib for AS patients. The drug is the first and only oral JAK inhibitor approved in the US for five indications. Continue Reading
-
News
17 Dec 2021
CHMP Issues Positive Opinion of J&J’s COVID-19 Vaccine Booster
In other COVID news, Pfizer re-confirms the efficacy of its COVID-19 vaccine booster shot and GSK and Sanofi’s COVID-19 booster elicits strong immune responses in a clinical trial. Continue Reading
-
News
15 Dec 2021
SAGE, WHO Support Johnson & Johnson COVID-19 Vaccine Booster
In a Phase 3 trial, J&J’s COVID-19 vaccine booster provided 100 percent protection at least 14 days post-final vaccination and 75 percent protection against symptomatic COVID-19 globally. Continue Reading
-
News
14 Dec 2021
Moderna Launches Artificial Intelligence Academy for mRNA Therapies
The initiative will educate Moderna employees to integrate artificial intelligence and machine learning solutions into every system and process. Continue Reading
-
News
14 Dec 2021
GSK Welcomes Gavi Decision to Fund Routine Malaria Vaccines for Kids
GSK’s malaria vaccine, RTS,S/AS01 e, is the first and only malaria vaccine to significantly reduce malaria in children in pivotal long-term clinical trials. Continue Reading
-
News
08 Dec 2021
FDA Approves Imaging Drug to Identify Ovarian Cancer
FDA approves Cytalux to improve the ability to locate additional ovarian cancerous tissue that is generally difficult to detect. Continue Reading
-
News
07 Dec 2021
J&J Considers Licensing COVID-19 Vaccine to South African Company
The agreement would allow for the first manufacturing and distribution of a COVID-19 vaccine sold by an African company for people living in Africa. Continue Reading
-
News
06 Dec 2021
CVS Health Initiatives Increase Affordability, Access To Medicine
CVS Health announces several steps to support its strategy to make healthcare more convenient, affordable, and accessible. Continue Reading
-
News
06 Dec 2021
Specialty Drugs Accounted for Half of Medicaid Spending in 2020
Magellan Health’s trend report found that specialty drugs, including Mavyret and Trikafta, made up 51.4% of Medicaid spending last year. Continue Reading
-
News
02 Dec 2021
FDA Addresses Impacts of New Variant, Urges COVID-19 Vaccinations
FDA is actively evaluating the potential impacts of the new COVID variant on currently available vaccines and urges COVID-19 vaccinations or booster shots. Continue Reading
-
News
01 Dec 2021
Johnson & Johnson Evaluates COVID-19 Vaccine Against New Variant
In other COVID news, Moderna updates its strategy to address the new variant, Omicron, and Thermo Fisher finds that two of its COVID-19 tests detect Omicron. Continue Reading
-
News
30 Nov 2021
GSK Appoints Phil Dormitzer Global Head of Vaccines, Research
Dormitzer will report to Hal Barron, chief scientific officer and president of research and development of GSK. Continue Reading
-
News
29 Nov 2021
FDA Approves First Treatment for Children with Achondroplasia
In a Phase 3 study, patients receiving the achondroplasia drug grew an average of 1.57 centimeters taller than those receiving a placebo. Continue Reading
-
News
29 Nov 2021
CVS, Walgreens & Walmart Helped Fuel Opioid Crisis in Ohio Counties
The Ohio counties blamed CVS, Walgreens, and Walmart for not doing enough to stop the flow of prescription pills that caused an opioid crisis and cost each county about $1B. Continue Reading
-
News
23 Nov 2021
CDC Expands COVID-19 Vaccine Booster Shots To All Americans
The CDC stated that all Americans 18 years and older who have completed the primary series “should” get a COVID-19 vaccine booster shot of an FDA authorized vaccine. Continue Reading
-
News
23 Nov 2021
US Gov’t Purchases 10M Courses of Pfizer’s COVID-19 Antiviral
In other COVID news, AstraZeneca’s COVID-19 antibody reduced the risk of developing symptomatic virus by 83% and the EMA began evaluating Novavax’s application for its vaccine. Continue Reading
-
News
22 Nov 2021
FDA Grants Designation For Early-Stage Breast Cancer Blood Test
In previous studies, Datar Cancer Genetics’ blood test detected Stage 0 and Stage 1 breast cancers with high accuracy. Continue Reading
-
News
19 Nov 2021
FDA Expands Pfizer’s COVID-19 Vaccine Booster Authorization
FDA expands emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine booster shot to include individuals 18 years of age and older. Continue Reading
-
News
19 Nov 2021
FDA Approves Rare Blood Disease Injection For Adults
Two individual studies found that after 7.5 years of treatment with Besremi 61% of patients with the rare blood disease polycythemia vera saw a complete hematological response. Continue Reading
-
News
18 Nov 2021
Improved Diagnostic Testing Boosts Patient Experience, Study Finds
Abbott’s Beyond Intervention research program finds a growing demand for an industry-wide standard in diagnostic testing to optimize the patient experience. Continue Reading
-
News
18 Nov 2021
Pfizer, BioNTech, Zipline Deliver First COVID-19 Vaccines in Ghana
The first long-range drone delivery will allow for the distribution of nearly 50,000 doses of the Pfizer-BioNTech COVID-19 vaccine in Ghana. Continue Reading
-
News
15 Nov 2021
Abbott, ADA Initiative Addresses Diabetes Care Management in POC
This is the first initiative under the ADA’s Health Equity Now platform to address diabetes care management in people of color. The program will launch in Columbus, Ohio. Continue Reading
-
News
15 Nov 2021
J&J Increases Access To Its COVID-19 Vaccine Through COVAX
In other COVID news, the Japanese govt purchases 1.6M courses of Merck’s COVID-19 treatment and Moderna asks the EU to expand its COVID-19 vaccine to children 6 to 11 years of age. Continue Reading
-
News
12 Nov 2021
President Biden Nominates Former FDA Commissioner as Head of FDA
Former FDA commissioner, Robert Califf, will lead FDA and play a vital role in policy ambitions and manage the scrutiny of FDA’s drug approval process. Continue Reading
-
News
12 Nov 2021
CHMP Recommends Approval Of Roche’s COVID-19 Antibody Combination
The committee recommends the approval of Roche’s COVID-19 antibody combination based on positive data from Phase 3 trials, which found that the drug reduced risk of death by 20%. Continue Reading
-
News
10 Nov 2021
Merck’s COVID-19 Treatment Receives First Authorization in UK
The UK based its decision on the Phase 3 trial that found Merck’s COVID-19 treatment reduced the risk of hospitalization or death by nearly 50% in COVID-19 patients. Continue Reading
-
News
08 Nov 2021
FDA Approves Novartis’ Chronic Myeloid Leukemia Treatment
Novartis’ Scemblix is the first FDA-approved chronic myeloid leukemia treatment that binds to the ABL myristoyl pocket. Continue Reading
-
News
08 Nov 2021
CDC Recommends Pfizer- BioNTech COVID-19 Vaccine for Children
The CDC expands COVID-19 vaccine recommendations to nearly 28 million children for children five to 11 years of age in the US. Continue Reading
-
News
04 Nov 2021
Feds Purchases More Doses of Lilly’s COVID-19 Antibody Treatment
In other COVID news, the government purchases 50 million more doses of Pfizer’s COVID-19 vaccine and FDA needs more time to complete Moderna’s EUA request for its vaccine in adolescents. Continue Reading
-
News
03 Nov 2021
Novartis, Global Heart Hub to Combat Cardiovascular Disease
Novartis and Global Health Hub have unveiled a program aimed at reducing cardiovascular disease-related death. Continue Reading
-
News
02 Nov 2021
FDA Authorizes Thermo Fisher’s COVID-19 New Test Collection Method
Thermo Fisher can now run COVID-19 tests from saliva samples collected with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device on the Amplitude Solution. Continue Reading
-
News
01 Nov 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children
FDA based its decision on a Phase 2/3 trial that found two doses of the Pfizer-BioNTech COVID-19 vaccine to 90.7% effective in preventing COVID-19 in children aged five to 11. Continue Reading
-
News
28 Oct 2021
FDA Accepts Application for Novartis’ Diabetic Macular Edema Drug
FDA based its decision on the KITE and KESTREL trials, which studied Novartis’ diabetic macular edema drug in 926 patients in 36 countries. Both trials met their primary endpoint. Continue Reading
-
News
28 Oct 2021
New Pilot to Leverage API, AI for Enhanced Diagnostic Accuracy
The new interface will allow provider organizations and other healthcare technology companies to bring VisualDx’s CDS into third-party applications to boost overall diagnostic accuracy. Continue Reading
-
News
25 Oct 2021
FDA Approves Expansion of Gilead’s HIV Drug in Pediatric Patients
FDA approves a new low-dose tablet dosage form of Gilead’s HIV drug for younger children living with the disease. Continue Reading
-
News
22 Oct 2021
CDC Unanimously Recommends J&J, Moderna COVID-19 Vaccine Booster
CDC unanimously recommends a booster dose of the Johnson & Johnson and Moderna COVID-19 vaccines one day after FDA approval. Continue Reading
-
Answer
22 Oct 2021
CVS Health Says Pharmacists Key for Medication Adherence, Access
CVS Health works to empower pharmacists to become more involved in patient care, including boosting medication adherence, allowing for a more personalized and proactive approach to care. Continue Reading
-
News
21 Oct 2021
FDA Authorizes Moderna, J&J Booster COVID-19 Vaccine Dose
FDA grants emergency use authorization for both Moderna and Johnson & Johnson’s COVID-19 vaccine booster doses based on the totality of scientific evidence. Continue Reading
-
News
21 Oct 2021
FDA Approves Interchangeable Biosimilar for Inflammatory Diseases
The approval is the second interchangeable product that FDA has approved and the first interchangeable biosimilar to treat certain inflammatory diseases. Continue Reading
-
News
20 Oct 2021
FDA Approves First Treatment for Rare Disease Congenital Athymia
FDA based its approval on clinical studies, which found that the rare disease drug significantly improved survival of children with congenital athymia. Continue Reading
-
News
19 Oct 2021
FDA Recommends Booster Dose of Moderna’s COVID-19 Vaccine
An FDA committee unanimously voted to recommend the booster dose for adults at least six months following the primary series. Continue Reading
-
News
18 Oct 2021
FDA Recommends Authorization For J&J’s COVID-19 Vaccine Booster
FDA committee votes 19-0 to recommend the COVID-19 vaccine booster dose to adults two months after initial vaccination. Continue Reading
-
News
18 Oct 2021
Roche Receives Breakthrough Therapy for Alzheimer’s Disease
FDA based its decision on recent data from the ongoing SCarlet RoAD and Marguerite RoAD trials, which showed that Roche’s drug reduced a pathological hallmark of Alzheimer’s disease. Continue Reading
-
News
13 Oct 2021
Moderna to Build State-of-the-Art mRNA Facility in Africa
Moderna will invest nearly $500 million in the new facility, expected to include drug substance manufacturing with fill/finish and packaging capabilities at each site. Continue Reading
-
News
12 Oct 2021
FDA Grants Designation For Daiichi Sankyo’s Breast Cancer Treatment
FDA granted the designation based on data from a Phase 3 trial in which Enhertu reduced the risk of disease progression or death in HER2 positive breast cancer patients by 72%. Continue Reading
-
News
12 Oct 2021
J&J’s Chief Scientific Officer Paul Stoffels Announces Retirement
Paul Stoffels, who spearheaded the development of the Johnson & Johnson COVID-19 vaccine, will retire at the end of 2021. Continue Reading
-
News
11 Oct 2021
ViiV Healthcare Submits FDA Application for HIV Regimen
If approved, ViiV Healthcare’s single-tablet regimen will broaden the treatment options available for children living with HIV. Continue Reading
-
News
08 Oct 2021
Marketing Strategies to Boost Access to Prescription Medications
While individuals most often go to a drug store or pharmacy for prescription medications, mail-orders and online prescription services have increased over the past few years. Continue Reading
-
News
07 Oct 2021
FDA Approves Kite’s CAR T-Cell Therapy For Leukemia
Other recent FDA approvals include a rare liver disease drug for pruritus and AbbVie’s episodic migraine drug. Continue Reading
-
News
06 Oct 2021
FDA Approves Amgen’s Repatha for Autosomal Dominant Disease
FDA approved Repatha for pediatric patients with autosomal dominant disease, heterozygous familial hypercholesterolemia, as an adjunct to diet and other LDL-C lowering therapies. Continue Reading
-
News
05 Oct 2021
Francis Collins Resigns as Director of the NIH After 12 Years
Collins is the longest-serving presidentially appointed NIH director, serving three US presidents over 12 years. Continue Reading
-
News
30 Sep 2021
Eli Lilly and Company to Drop Insulin Costs 40% in the US
The new list price of the company’s insulin, effective January 2022, will be $82.41 for individual vials and $159.12 for a pack of five pens. Continue Reading
-
News
24 Sep 2021
COVID-19 Treatment Remdesivir Reduces Hospitalizations by 87%
In other COVID news, Canada approves Moderna’s COVID-19 vaccine and Pfizer and BioNTech will supply more vaccine doses to the US for donation to low-and lower-middle-income countries. Continue Reading
-
News
22 Sep 2021
Thermo Fisher Launches Enzyme Analyzers for Assay Applications
Thermo Fisher launches two enzyme analyzer systems to deliver fully automated incubation settings, reagent additions, and precise measurement calculations. Continue Reading
-
News
16 Sep 2021
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
In other COVID news, Novavax launches a clinical trial of its combination COVID-19/ flu vaccines and Takeda will manufacture 150M doses of Novavax’s COVID-19 vaccine in Japan. Continue Reading
-
News
14 Sep 2021
Thermo Fisher Launches Portfolio to Advance Quantitative Analysis
The new mass spectrometry portfolio will boost quantitative analysis, increase workflow throughput through polarity speeds, and boost sensitivity for key target applications. Continue Reading
-
News
09 Sep 2021
FDA Approves Johnson & Johnson’s Schizophrenia Injectable
Other recent FDA approvals include Merck’s Keytruda for bladder cancer and BeiGene’s Brukinsa to treat adult patients with Waldenström’s macroglobulinemia. Continue Reading
-
News
08 Sep 2021
Novartis Boosts Access to Cholesterol-Lowering RNA Therapy
Novartis and NHS England will boost access to the RNA therapy for patients across England who have persistently elevated LDL cholesterol levels and a history of certain cardiovascular events. Continue Reading
-
News
07 Sep 2021
Moderna Submits Initial Data to FDA for COVID-19 Vaccine Booster
In other COVID news, Merck launches a Phase 3 trial for its COVID-19 treatment and GSK and SK biosciences initiate a trial of SK’s COVID-19 vaccine in combination with GSK’s pandemic adjuvant. Continue Reading
-
News
03 Sep 2021
Top Manufacturers of Most Prescribed Drugs in Medicare
Top manufacturers of the most prescribed drugs in both Medicare Part B and Medicare Part D include Bristol Myers Squibb, Roche, Johnson & Johnson, Merck, and Pfizer. Continue Reading
-
News
02 Sep 2021
AMA, APhA, ASHP Call for Immediate End to Ivermectin for COVID-19
The organizations urged physicians, pharmacists, and other prescribers to warn patients against the use of ivermectin outside of FDA-approved indications and guidance. Continue Reading
-
News
02 Sep 2021
Pfizer, BioNTech COVID-19 Vaccine Expands to Latin America
Eurofarma will manufacture doses of Pfizer and BioNTech's COVID-19 vaccine within the company’s global vaccine supply chain and manufacturing network. Continue Reading
-
News
02 Sep 2021
FDA Approves Vivistim System for Chronic Ischemic Stroke
Other FDA approvals include an injection to treat pediatric patients with growth failure and an injection to treat moderate to severe pruritus associated with chronic kidney disease. Continue Reading
-
News
27 Aug 2021
Role of Digital Therapeutics in Chronic Disease Management
Digital therapeutics deliver evidence-based therapeutic interventions to patients to enhance chronic disease management and offer more treatment options. Continue Reading
-
News
23 Aug 2021
Pfizer-BioNTech COVID-19 Vaccine Gets Full FDA Approval
The COVID-19 vaccine is approved for individuals 16 years of age and older and marketed as Comirnaty. Continue Reading
-
News
20 Aug 2021
New CEO to Take Over for Gorsky at Johnson & Johnson
Alex Gorsky, who has been at Johnson & Johnson for over 30 years, will now serve as executive chairman, with Joaquin Duato taking over as chief executive officer role. Continue Reading
-
News
18 Aug 2021
FDA Approves New Indication for Chronic Disease Treatment
The chronic disease treatment, Xywav, is approved to treat cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. Continue Reading
-
News
17 Aug 2021
UPMC Expands Access to Monoclonal COVID-19 Antibody Treatments
Patients will now be able to receive the COVID-19 antibody treatments if they have been exposed to someone with the virus and are unvaccinated or if they are at risk of serious illness. Continue Reading
-
News
16 Aug 2021
NCQA Program Supports Best Practices in Specialty Pharmacy
The program helps pharmacies show commitment to quality improvement and identify barriers to therapy initiation and adherence in specialty pharmacy. Continue Reading
-
News
13 Aug 2021
Most Important FDA Novel Drug Approvals of 2021, So Far
FDA novel drug approvals in 2021 have so far included drugs treating certain cancers, Alzheimer’s disease, and Multiple Sclerosis. Continue Reading
-
News
12 Aug 2021
Novavax’s COVID-19 Vaccine Booster Neutralizing Antibody Levels
In other COVID news, Australia grants provisional registration to Moderna’s COVID-19 vaccine and Thermo Fisher updates the SARS-CoV-2 mutation panel to detect various COVID-19 strains. Continue Reading
-
News
12 Aug 2021
FDA Accepts Merck’s Keytruda Application for Endometrial Carcinoma
Merck based its application on overall response data from the KEYNOTE-158 trial, evaluating Keytruda in various types of advanced solid tumors, including endometrial carcinoma. Continue Reading
-
News
09 Aug 2021
FDA Broadens Authorization for Eli Lilly’s COVID-19 Treatment
In other COVID news, AstraZeneca’s COVID-19 vaccine and an mRNA vaccine were similar in a real-world study, and GSK and Vir will supply the EU with 22,000 doses of their COVID-19 treatment. Continue Reading
-
News
06 Aug 2021
FDA Approves GSK’s Antibody for Chronic Disease Management
Other recent FDA approvals include J&J’s pulmonary arterial hypertension therapy and an expanded label approval for AbbVie’s BOTOX for upper limb spasticity in adults. Continue Reading
-
News
02 Aug 2021
UIC Awarded $6M to Test COVID-19 Drug Candidate For Lung Damage
UIC will use the funding to test COVID-19 drug candidate VT-109 in animal models of acute respiratory distress syndrome (ARDS), a complication from the SARS-CoV-2 virus. Continue Reading
-
News
29 Jul 2021
AstraZeneca’s COVID-19 Vaccine 82% Effective Against Variants
In other COVID news, the US purchased an additional 200M doses of the Pfizer-BioNTech COVID-19 vaccine while Japan will purchase an additional 50M doses of Moderna’s vaccine. Continue Reading
-
News
28 Jul 2021
FDA Approves Merck’s Keytruda Treatment for Endometrial Carcinoma
Other FDA approvals include AstraZeneca’s type 2 diabetes treatment, a rare genetic disorder treatment, and AbbVie’s treatment for acute bacterial skin and skin structure infections. Continue Reading
-
News
27 Jul 2021
Bristol Myers Squibb Pulls Immunotherapy Opdivo from US Market
The move follows the FDA Advisory Committee’s evaluation of accelerated approvals for checkpoint inhibitors that did not meet their post-marketing requirements. Continue Reading
-
News
27 Jul 2021
Pharmaceutical Supply Chain Needs Reform for Transparency, Access
An expert committee has developed 70 reform recommendations for the pharmaceutical supply chain to increase transparency, access, and affordability. Continue Reading
-
News
22 Jul 2021
FDA Approves Sanofi’s All-Oral Treatment for Sleeping Sickness
Other FDA approvals include a treatment for adult and pediatric patients with chronic graft-versus-host disease and tablets for complications associated with chronic kidney disease. Continue Reading
-
News
16 Jul 2021
St. Jude Medical to Pay $27M to Resolve Healthcare Fraud Allegations
Federal officials alleged that the medical device manufacturer sold defective heart devices to healthcare facilities between November 2014 and October 2016. Continue Reading
-
News
13 Jul 2021
Gavi Signs Agreement for Sinopharm, Sinovac COVID-19 Vaccine Doses
The COVID-19 vaccine doses will be made available from July to December 2021 to help address immediate and critical gaps in supply. Continue Reading
-
News
12 Jul 2021
Pfizer, AbbVie, Biogen Launch Resource for Genetic Variants
The world’s largest resource for genetic variants gives access to results from analyses of whole-exome sequencing data from 300,000 UK Biobank research participants. Continue Reading
-
News
09 Jul 2021
FDA: Aduhelm Only to Be Given to Early-Stage Alzheimer’s Patients
FDA has reversed its broad approval for the Alzheimer’s drug after the first 87-year-old patient who received the medication in Chicago saw disease progression. Continue Reading
-
News
09 Jul 2021
Improving Health Equity Across the Pharmaceutical Industry
Bristol Myers Squibb is working to enhance health equity and expand the reach of its medicines, particularly for medically underserved and increasingly diverse patient populations. Continue Reading
-
News
07 Jul 2021
J&J COVID-19 Vaccine Neutralizes Activity Against Delta Variant
In other COVID news, Novavax's COVID-19 vaccine is 89.7% effective in a Phase 3 trial and Moderna announces Recipharm site to manufacture vaccine in France. Continue Reading
-
News
06 Jul 2021
FDA Approves Key Component for Common Childhood Cancer Treatment
Other recent FDA approvals include Direct Biologics Phase 1/2 trial application for its COVID-19 treatment and Angel Medical Systems cardiac detection monitor for ACS patients. Continue Reading
-
News
30 Jun 2021
Walmart Analog Insulin to Streamline Diabetes Care Management
Walmart is looking to private brand analog insulin to control high blood sugar in adults and children with diabetes and revolutionize the costs of effective diabetes care management. Continue Reading
-
News
30 Jun 2021
Moderna’s COVID-19 Vaccine Elicits Activity Against All Variants
In other COVID news, AstraZeneca’s COVID-19 vaccine elicits a strong immune response after third boosting dose and Abbott receives CE mark for its rapid COVID-19 antigen self-test. Continue Reading
-
News
28 Jun 2021
US Pauses All Distribution of Eli Lilly’s COVID-19 Antibody
US paused the distribution of Eli Lilly’s COVID-19 antibody treatment after the CDC identified that the treatment may not be active against the Brazil or South African coronavirus variants. Continue Reading
-
News
24 Jun 2021
FDA Approves Boehringer’s Pediatric Oral Blood Thinner
Other recent FDA approvals include an edema drug for patients with heart failure, a systemic mastocytosis treatment, and a nasal antihistamine for allergic rhinitis. Continue Reading
-
News
22 Jun 2021
Aduhelm to Boost Prescription Drug Spending Over $73B by 2028
By mid 2020, Biogen’s Alzheimer’s drug, Aduhelm, may constitute more than 1% of all national healthcare spending and increase total prescription drug spending by over 8%. Continue Reading
-
News
22 Jun 2021
Gilead’s Remdesivir Lowers Risk of Mortality in COVID-19 Patients
In other COVID news, GSK and Vir confirm the efficacy of their coronavirus antibody in COVID-19 patients, and AstraZeneca will supply 300M doses of its vaccine to the EU by the end of September. Continue Reading
-
News
21 Jun 2021
CRISPR Therapeutics, Capsida Collaborate to Develop Gene Therapies
The companies will leverage adeno-associated virus vectors to develop gene therapies for the treatment of ALS and Friedreich’s ataxia. Continue Reading
-
News
18 Jun 2021
Biden Invests Over $3B to Boost COVID-19 Antiviral Development
The initiative, called the Antiviral Program for Pandemics, is part of the Biden Administration’s whole-of-government strategy to develop the next generation of COVID-19 antiviral medicines. Continue Reading
-
News
18 Jun 2021
Thermo Fisher Uses Next-Generation Sequencing to ID COVID Variants
The panel leverages next-generation sequencing, allowing researchers to obtain insights and identify new and known COVID-19 variants with rapid-turnaround time. Continue Reading
-
News
17 Jun 2021
Pfizer’s Drug Helps COVID-19 Patients Hospitalized with Pneumonia
The US also purchased an additional 200 million doses of Moderna’s COVID-19 vaccine and AstraZeneca’s vaccine is effective in COVID-19 patients infected with the Delta variant. Continue Reading
-
News
15 Jun 2021
FDA Approves Novo Nordisk’s Obesity Drug Wegovy
In addition to the obesity drug, FDA approves the first treatment for patients with plasminogen deficiency type 1 and Chimerix Inc’s Tembexa to treat smallpox. Continue Reading
-
News
14 Jun 2021
3 FDA Committee Members Resign Over Alzheimer’s Drug Approval
Following the approval of Biogen’s Alzheimer’s drug last week, 3 FDA advisory committee members have resigned after FDA ignored their input during the decision-making process. Continue Reading
-
News
11 Jun 2021
Pfizer, BioNTech Give US 500M Doses of COVID-19 Vaccine
In other COVID news, Moderna files for FDA emergency use authorization for its COVID-19 vaccine and Roche receives CE mark for its SARS-CoV-2 Antigen Self-Test Nasal. Continue Reading